Prostate Cancer
Development and Internal Validation of a Novel Model to Identify the Candidates for Extended Pelvic Lymph Node Dissection in Prostate Cancer.
January 16, 2024
Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer Patients: A Systematic Review.
January 16, 2024
Genetic risk and likelihood of prostate cancer detection on first biopsy by ancestry.
January 15, 2024
Development of PARP inhibitors in advanced prostate cancer.
January 15, 2024
Surgical Management and Considerations for Patients with Localized High-Risk Prostate Cancer.
January 15, 2024
Detection of Extracellular Vesicle-Derived RNA as Potential Prostate Cancer Biomarkers: Role of Cancer-type SLCO1B3 and ABCC3.
January 15, 2024
Real-world economic burden of metastatic castration-resistant prostate cancer before and after first-line therapy initiation.
January 12, 2024
Cell-Free DNA Genomic Profiling and Its Clinical Implementation in Advanced Prostate Cancer.
January 12, 2024
Non-invasive detection of neuroendocrine prostate cancer through targeted cell-free DNA methylation.
January 12, 2024
Genomic classifiers and prognosis of localized prostate cancer: a systematic review.
January 12, 2024
Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging.
January 12, 2024
Radiation Therapy Summary of the AUA/ASTRO Guideline on Clinically Localized Prostate Cancer.
January 11, 2024
Do Phosphodiesterase Type 5 Inhibitors Increase the Risk of Biochemical Recurrence After Radical Prostatectomy?
January 11, 2024